Comparison of Gadobenate Dimeglumine and Gadodiamide in the Evaluation of Spinal Vascular Anatomy with MR Angiography
Open Access
- 6 January 2010
- journal article
- research article
- Published by American Society of Neuroradiology (ASNR) in American Journal Of Neuroradiology
- Vol. 31 (6), 1151-1156
- https://doi.org/10.3174/ajnr.a1974
Abstract
BACKGROUND AND PURPOSE: Spinal MRA has been increasingly used to evaluate non-invasively the spinal cord vasculature. Our aim was to prospectively compare gadobenate dimeglumine with gadodiamide in the assessment of the normal spinal cord vasculature by using contrast-enhanced MRA, with the hypothesis that high T1 relaxivity gadolinium compounds may improve visualization of the intradural vessels. MATERIALS AND METHODS: Twenty subjects underwent 2 temporally separated contrast-enhanced spinal MRAs with gadobenate dimeglumine and gadodiamide (0.2 mmol/kg). Two blinded observers rated postprocessed images on the following qualitative parameters: background homogeneity, sharpness, vascular continuity, and contrast enhancement. Delineation of the ASA, AKA, hairpin configuration of the ASA-AKA connection, and visualized ASA length were recorded. Each observer indicated which of the 2 matched studies he or she thought was of the best overall diagnostic quality. RESULTS: According to both observers gadobenate dimeglumine was superior to gadodiamide in the representation of vascular continuity and contrast (P value < .05). Background homogeneity was not significantly different between the studies. One observer favored gadobenate dimeglumine over gadodiamide in the demonstration of vascular sharpness, while the second observer did not find any significant difference between contrast agents. There was no significant difference between contrast agents in the visualization of the ASA, AKA, hairpin-shaped ASA-AKA connection, and visualized length of the ASA. The overall quality of the gadobenate dimeglumine–enhanced MRA was deemed superior in 15 and 16 cases, respectively, by the 2 observers. CONCLUSIONS: Improved image quality and vascular contrast enhancement of spinal MRA at 1.5T is achieved with high T1 relaxivity gadolinium contrast agents compared with conventional agents at equivalent doses.Keywords
This publication has 35 references indexed in Scilit:
- Nephrogenic Systemic Fibrosis: Incidence, Associations, and Effect of Risk Factor Assessment—Report of 33 CasesRadiology, 2009
- Advances in Spinal Cord MR AngiographyAmerican Journal Of Neuroradiology, 2008
- Case-control study of gadodiamide-related nephrogenic systemic fibrosisNephrology Dialysis Transplantation, 2007
- Imaging in Spinal Vascular DiseaseNeuroimaging Clinics Of North America, 2007
- Usefulness of Preoperative Detection of Artery of Adamkiewicz with Dynamic Contrast-enhanced MR AngiographyRadiology, 2005
- Contrast‐enhanced MR angiography of the run‐off vasculature: Intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumineJournal of Magnetic Resonance Imaging, 2003
- Prospective Blinded Evaluation of Gd-DOTA– versus Gd-BOPTA–enhanced Peripheral MR Angiography, as Compared with Digital Subtraction AngiographyRadiology, 2003
- Assessment of Gadobenate Dimeglumine for Magnetic Resonance AngiographyInvestigative Radiology, 2002
- Renal Time-resolved MR Angiography: Quantitative Comparison of Gadobenate Dimeglumine and Gadopentetate Dimeglumine with Different DosesRadiology, 2001
- Gadolinium Chelates with Weak Binding to Serum ProteinsInvestigative Radiology, 1997